- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/76 - Virus; Particules sous-virales; Bactériophages
Détention brevets de la classe A61K 35/76
Brevets de cette classe: 3151
Historique des publications depuis 10 ans
131
|
170
|
223
|
249
|
306
|
299
|
301
|
287
|
198
|
69
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
iNtRON Biotechnology, Inc. | 176 |
87 |
The Trustees of the University of Pennsylvania | 4122 |
66 |
The Regents of the University of California | 18943 |
57 |
University of Massachusetts | 2130 |
37 |
CJ Cheiljedang Corporation | 2964 |
35 |
Ottawa Hospital Research Institute | 102 |
26 |
The University of North Carolina at Chapel Hill | 1928 |
26 |
University of Florida Research Foundation, Inc. | 3883 |
25 |
Osaka University | 3143 |
23 |
Takeda Pharmaceutical Company Limited | 2961 |
19 |
Keio University | 1053 |
19 |
Ohio State Innovation Foundation | 1770 |
19 |
Oncolytics Biotech Inc. | 52 |
19 |
Armata Pharmaceuticals, Inc. | 29 |
19 |
Institut Pasteur | 798 |
18 |
Technophage, Investigacao e Desenvolvimento EM Biotecnologia, SA | 40 |
17 |
Voyager Therapeutics, Inc. | 206 |
17 |
Massachusetts Institute of Technology | 9795 |
16 |
Toray Industries, Inc. | 6652 |
16 |
Memorial Sloan-Kettering Cancer Center | 1789 |
16 |
Autres propriétaires | 2574 |